Shopping Cart
Remove All
Your shopping cart is currently empty
HPK1-IN-35 is a potent, selective inhibitor of HPK1, demonstrating an IC50 value of 3.5 nM. This compound reduces p-SLP76 expression and facilitates the secretion of IL-2 [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $1,980 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $2,500 | 8-10 weeks | 8-10 weeks |
| Description | HPK1-IN-35 is a potent, selective inhibitor of HPK1, demonstrating an IC50 value of 3.5 nM. This compound reduces p-SLP76 expression and facilitates the secretion of IL-2 [1]. |
| Targets&IC50 | HPK1:3.5 nM |
| In vitro | HPK1-IN-35 (compound 31) reduces anti-CD3 antibody (1 µg/mL)-stimulated p-SLP76 expression dose-dependently at concentrations of 0.1, 0.3, 1, and 3 µM after 1 hour of treatment [1]. Furthermore, HPK1-IN-35 enhances IL-2 secretion from Jurkat cells in a dose-dependent manner within the range of 0-10 µM over 24 hours, with an EC50 value of 1.19 µM [1]. |
| Molecular Weight | 584.69 |
| Formula | C30H32N8O3S |
| Cas No. | 2935903-77-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.